Gamida Cell Ltd. financial data

Location
Jerusalem, Israel
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2024 - 23 May 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 133% % -48%
Quick Ratio 5% %
Return On Equity 527% % -97%
Return On Assets -60% % 15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 154,013,109 shares 27%
Common Stock, Shares, Outstanding 154,050,953 shares 88%
Common Stock, Value, Issued $416,000 USD 87%
Weighted Average Number of Shares Outstanding, Basic 152,711,493 shares 99%
Weighted Average Number of Shares Outstanding, Diluted 152,711,493 shares 99%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $890,000 USD
Cost of Revenue $916,000 USD
Research and Development Expense $18,404,000 USD -54%
Operating Income (Loss) $78,594,000 USD -4.4%
Nonoperating Income (Expense) $16,612,000 USD
Net Income (Loss) Attributable to Parent $61,982,000 USD 23%
Earnings Per Share, Basic 0.13 USD/shares -52%
Earnings Per Share, Diluted 0.13 USD/shares -52%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $24,776,000 USD -47%
Accounts Receivable, after Allowance for Credit Loss, Current $1,027,000 USD
Inventory, Net $1,966,000 USD
Assets, Current $33,358,000 USD -31%
Property, Plant and Equipment, Net $40,223,000 USD -12%
Operating Lease, Right-of-Use Asset $2,779,000 USD -41%
Other Assets, Noncurrent $2,821,000 USD 123%
Assets $79,558,000 USD -24%
Accounts Payable, Current $5,433,000 USD 24%
Employee-related Liabilities, Current $5,041,000 USD 16%
Liabilities, Current $94,701,000 USD 325%
Operating Lease, Liability, Noncurrent $1,849,000 USD -38%
Other Liabilities, Noncurrent $1,457,000 USD -47%
Liabilities $98,288,000 USD
Retained Earnings (Accumulated Deficit) $499,774,000 USD -14%
Stockholders' Equity Attributable to Parent $18,730,000 USD -22%
Liabilities and Equity $79,558,000 USD -24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,998,000 USD -3.2%
Net Cash Provided by (Used in) Financing Activities $1,331,000 USD -74%
Net Cash Provided by (Used in) Investing Activities $89,000 USD 89%
Common Stock, Shares Authorized 325,000,000 shares 117%
Common Stock, Shares, Issued 154,204,735 shares 88%
Common Stock, Par or Stated Value Per Share 0.01 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $21,778,000 USD -22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24,776,000 USD -47%
Interest Paid, Excluding Capitalized Interest, Operating Activities $2,301,000 USD 4.4%
Operating Lease, Liability $2,984,000 USD
Depreciation $1,130,000 USD 966%
Payments to Acquire Property, Plant, and Equipment $89,000 USD -89%
Lessee, Operating Lease, Liability, to be Paid $3,120,000 USD -43%
Operating Lease, Liability, Current $1,135,000 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year Two $683,000 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,038,000 USD -49%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure -29%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $136,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $520,000 USD -47%
Share-based Payment Arrangement, Expense $3,857,000 USD 12%